Evidence map›Paper›PMID 24827998›Full record

ArticleRadiology2014

Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.

Olivier Gevaert, Lex A Mitchell, Achal S Achrol, Jiajing Xu, Sebastian Echegaray, Gary K Steinberg, Samuel H Cheshier, Sandy Napel, Greg Zaharchuk, Sylvia K Plevritis

Erratum issuedAbstract read
In one paragraph

Article in Radiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 170 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
170citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

170 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. The application of radiomics in laryngeal cancer.The British journal of radiology · 2021
    Pooled it
  3. TCGA-TCIA Impact on Radiogenomics Cancer Research: A Systematic Review.International journal of molecular sciences · 2019
    Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Radiomics in laryngeal squamous cell carcinoma: state of the art.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

110 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Olivier GevaertFrom the Departments of Medicine (O.G.), Radiology (O.G., L.A.M., J.X., S.E., S.N., G.Z., S.K.P.), and Neurosurgery (A.S.A., G.K.S., S.H.C.), Stanford University, 1265 Welch Rd, Stanford, CA, 94304-5479.
Lex A Mitchell
Achal S Achrol
Jiajing Xu
Sebastian Echegaray
Gary K Steinberg
Samuel H Cheshier
Sandy Napel
Greg Zaharchuk
Sylvia K Plevritis

Funding

MODELING THE ROLE OF PROGRESSION IN FOLLICULAR LYMPHOMAU54CA149145 · NCI · STANFORD UNIVERSITY · PI PLEVRITIS, SYLVIA KATINA · 2010 to 2014
$12.1M
Tools for Linking and Mining image and Genomic Data in Non-Small Cell Lung CancerR01CA160251 · NCI · STANFORD UNIVERSITY · PI NAPEL, SANDY A., PLEVRITIS, SYLVIA KATINA · 2011 to 2015
$2.9M
NCI NIH HHS R01 CA160251NCI NIH HHS U54 CA149145
6 · The paper itself

Abstract

purposeTo derive quantitative image features from magnetic resonance (MR) images that characterize the radiographic phenotype of glioblastoma multiforme (GBM) lesions and to create radiogenomic maps associating these features with various molecular data. MATERIALS AND

methodsClinical, molecular, and MR imaging data for GBMs in 55 patients were obtained from the Cancer Genome Atlas and the Cancer Imaging Archive after local ethics committee and institutional review board approval. Regions of interest (ROIs) corresponding to enhancing necrotic portions of tumor and peritumoral edema were drawn, and quantitative image features were derived from these ROIs. Robust quantitative image features were defined on the basis of an intraclass correlation coefficient of 0.6 for a digital algorithmic modification and a test-retest analysis. The robust features were visualized by using hierarchic clustering and were correlated with survival by using Cox proportional hazards modeling. Next, these robust image features were correlated with manual radiologist annotations from the Visually Accessible Rembrandt Images (VASARI) feature set and GBM molecular subgroups by using nonparametric statistical tests. A bioinformatic algorithm was used to create gene expression modules, defined as a set of coexpressed genes together with a multivariate model of cancer driver genes predictive of the module's expression pattern. Modules were correlated with robust image features by using the Spearman correlation test to create radiogenomic maps and to link robust image features with molecular pathways.

resultsEighteen image features passed the robustness analysis and were further analyzed for the three types of ROIs, for a total of 54 image features. Three enhancement features were significantly correlated with survival, 77 significant correlations were found between robust quantitative features and the VASARI feature set, and seven image features were correlated with molecular subgroups (P < .05 for all). A radiogenomics map was created to link image features with gene expression modules and allowed linkage of 56% (30 of 54) of the image features with biologic processes.

conclusionRadiogenomic approaches in GBM have the potential to predict clinical and molecular characteristics of tumors noninvasively. Online supplemental material is available for this article.

Indexed as

Gene Expression Regulation, NeoplasticAlgorithmsBrain NeoplasmsContrast MediaFemaleGlioblastomaHumansImage EnhancementImage Interpretation, Computer-AssistedMagnetic Resonance ImagingMaleNecrosisPhenotypeSurvival RateContrast Media

Identifiers

PMID24827998
PMCPMC4263772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.